Find stats on top websites
The healthcare technology and pharmacy services industry is rapidly evolving, driven by demand for value-based care, remote monitoring, and personalized medicine. Independent pharmacies are transforming into clinical hubs, leveraging AI and digital platforms to offer advanced services. Regulatory changes and technological advancements are accelerating this shift, aiming for improved patient outcomes and cost reduction.
Total Assets Under Management (AUM)
US Digital Health Market Size in United States
~226 billion USD (2023)
(15-20% CAGR)
- Digital health market includes mHealth, health information technology, telehealth, and healthcare analytics.
- Driven by increased adoption of remote patient monitoring and AI in healthcare.
- Focus on improving patient engagement and reducing healthcare costs.
226 billion USD
Generative AI can revolutionize clinical decision support by synthesizing vast amounts of patient data and medical literature to provide personalized treatment recommendations and predict patient outcomes for pharmacists and physicians.
Blockchain technology can enhance the security and interoperability of health data exchange, creating a secure, transparent, and immutable record of patient information across disparate systems and providers.
Next-generation RPM devices with enhanced biosensors and real-time data analytics will offer more comprehensive and accurate patient insights, facilitating proactive and personalized care interventions.
The CMS Final Rule for Medicare Physician Fee Schedule (MPFS) 2024 includes updates to payment policies for physician services, including those related to remote monitoring and chronic care management, impacting reimbursement for services offered by pharmacies under physician oversight.
This policy directly impacts Truentity Health by affecting reimbursement rates for RPM, TCM, and other clinical services facilitated through their platform, influencing the revenue potential for participating pharmacies.
The Information Blocking Rule, stemming from the 21st Century Cures Act, prevents healthcare providers, health IT developers, and health information exchanges from knowingly interfering with the access, exchange, or use of electronic health information (EHI).
This regulation promotes seamless data exchange, which is critical for Truentity Health's integrated platform, but also necessitates strict adherence to data sharing protocols and compliance to avoid penalties.
The Inflation Reduction Act of 2022 includes significant changes to Medicare Part D, such as capping out-of-pocket prescription drug costs for beneficiaries and allowing Medicare to negotiate drug prices, impacting pharmacy reimbursement and medication adherence strategies.
These changes could influence pharmacy dispensing revenues and shift focus towards enhanced medication management services, potentially increasing demand for Truentity Health's MTM and adherence programs.
Sign up now and unleash the power of AI for your business growth